Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamine amidotransferases (GATases) are a family of enzymes that catalyze the removal of the amide nitrogen from glutamine and transfer it to a specific substrate, forming a new carbon-nitrogen bond on that substrate. This reaction is central to the biosynthesis of nucleotides, amino acids, glycoproteins, and enzyme cofactors, making GATases key metabolic enzymes essential for cell proliferation. They hydrolyze glutamine to generate ammonia (NH₃), which is then transferred to an acceptor molecule via two half-reactions. Many GATases use a catalytic triad composed of cysteine, histidine, and glutamate residues in their active site. Examples of enzymes containing GAT domains include anthranilate synthase component II, CTP synthetase, GMP synthetase, and carbamoyl-phosphate synthetases.
Inhibition of glutamine utilization for nucleotide/amino acid biosynthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamine Amidotransferase (None).